xCures Announces Collaboration with CancerCompass
Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures' platform and services.Consumers who [...]
Bringing Value-Based Insurance Design to Oncology
Although the oncology field has been increasingly adopting value-based insurance designs, much work yet remains. For decades, the traditional dogma [...]
The Disturbing Dearth of Evidence for Supportive Oncology
Despite historical reliance on evidence generated from randomized controlled trials (RCTs), there has been a surge in the number of [...]
[Podcast] Telehealth, Standardizing Care, and Drug Prices in Oncology With Dr. Vincent Rajkumar
Tune to this podcast for a discussion on telehealth in oncology with Vincent Rajkumar, MD. As he lends his insights [...]
Pay-for-Performance Program Increased Evidence-Based Prescribing of Cancer Drugs
Increased prescribing rates of evidence-based cancer drugs may be achieved without a concomitant change in total spending on care through [...]
Can Real-World Data Help Overcome Cancer’s Financial Toxicity?
Cancer, second only to heart disease, is one of the most expensive conditions to treat. Costs for treatment continue to [...]
Free Strategic Playbook Aims to Bring Cures to Patients More Efficiently
Harvard Business School’s Kraft Precision Medicine Accelerator announced the launch of a playbook specifically developed to bring vital assistance to [...]
Incorporating Value-based Care Into Oncology
Value-based care within insurance design utilizes evidence-based medicine to distinguish high-value and low-value diagnostics and treatments. The goals of value-based [...]
New Platform for Affordable Genomic Cancer Profiling Launched
A next-generation sequencing reference laboratory will use artificial intelligence (AI) to advance precision medicine to determine genomic signatures, first for [...]
Research Finds Lower Care Costs with Increased Use of New Drugs for Treatment of Pancreatic Cancer Patients
The results of a new study by Tyme Technologies, Inc., suggests the increased use of novel drugs in the treatment [...]
Report Highlights Payer Challenges of Specialized Cancer Treatments
A new FirstWord report takes a deep dive into the payer's perspective on specialized cancer treatments to reveal how pharmaceutical [...]
Study: Cancer Drug Costs Double at Hospitals
A new study by the Employee Benefit Research Institute Center for Research on Health Benefits Innovation suggests cancer medicines have [...]
